•
Mar 31, 2023

Cardlytics Q1 2023 Earnings Report

Announced financial results for the first quarter ended March 31, 2023.

Key Takeaways

Cardlytics' Q1 2023 revenue was $64.3 million, a decrease of 5% year-over-year. Net income attributable to common stockholders was $13.6 million, or $0.40 per diluted share. Cardlytics MAUs were 188.8 million, an increase of 6% year-over-year.

Revenue was $64.3 million, a decrease of (5)% year-over-year.

Billings was $95.6 million, a decrease of (3)% year-over-year.

Gross profit was $24.5 million, a decrease of (7)% year-over-year.

Net income attributable to common stockholders was $13.6 million, or $0.40 per diluted share.

Total Revenue
$64.3M
Previous year: $67.9M
-5.3%
EPS
-$0.25
Previous year: -$0.38
-34.2%
Monthly Active Users
188.8M
Previous year: 178.5M
+5.8%
Average Revenue per User
$0.34
Previous year: $0.36
-5.6%
Gross Profit
$24.5M
Previous year: $26.2M
-6.5%
Cash and Equivalents
$139M
Previous year: $208M
-33.2%
Free Cash Flow
-$10.4M
Previous year: -$20.1M
-48.1%
Total Assets
$685M
Previous year: $1.23B
-44.4%

Cardlytics

Cardlytics

Forward Guidance

Cardlytics anticipates billings, revenue, adjusted contribution and adjusted EBITDA to be in the following ranges for Q2 2023: Billings $98.0 - $109.0 million, Revenue $65.0 - $74.0 million, Adjusted contribution $32.0 - 38.0 million, Adjusted EBITDA ($10.0) - ($6.0) million.